Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.930
+0.030 (1.58%)
At close: Apr 28, 2026, 4:00 PM EDT
1.960
+0.030 (1.55%)
After-hours: Apr 28, 2026, 6:23 PM EDT
Bluejay Diagnostics Employees
Bluejay Diagnostics had 6 employees as of December 31, 2025. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,141,414
Market Cap
2.00M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6 | -1 | -14.29% |
| Dec 31, 2024 | 7 | -3 | -30.00% |
| Dec 31, 2023 | 10 | -6 | -37.50% |
| Dec 31, 2022 | 16 | 7 | 77.78% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| WORK Medical Technology Group LTD | 238 |
| Beyond Air | 61 |
| Intelligent Bio Solutions | 55 |
| Tivic Health Systems | 52 |
| Nuwellis | 38 |
| Catheter Precision | 22 |
| ENvue Medical | 14 |
| Autonomix Medical | 11 |
BJDX News
- 21 days ago - Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial - GlobeNewsWire
- 6 weeks ago - Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting - GlobeNewsWire
- 6 weeks ago - NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics - GlobeNewsWire
- 2 months ago - Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised - GlobeNewsWire
- 2 months ago - Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026 - GlobeNewsWire
- 4 months ago - Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production - GlobeNewsWire
- 7 months ago - Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 7 months ago - Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire